Early research (Phase 1)Study completedNCT01498952
What this trial is testing
MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
Who this might be right for
Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
MedImmune LLC 6
Showing 20 of 0 results